Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOFACITINIB vs TOFERSEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOFACITINIB vs TOFERSEN: Safety Overview

Metric TOFACITINIB TOFERSEN
Total FAERS Reports 155,647 366
Deaths Reported 7,847 60
Death Rate 5.0% 16.4%
Hospitalizations 21,976 97
Average Patient Age 57.6 yrs 56.9 yrs
% Female Patients 81.6% 48.3%
FDA Approval Date Aug 19, 2021 Apr 25, 2023
Manufacturer Pfizer Laboratories Div Pfizer Inc Biogen Inc.
Route ORAL INTRATHECAL
Marketing Status Prescription Prescription